v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net income $ 923.5 $ 978.2
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 128.5 113.9
Non-cash operating lease cost 19.8 19.3
Stock-based compensation (Note 10) 133.6 118.9
Impairment of intangible and long-lived assets (Note 2) 220.2 40.0
Change in fair value of contingent consideration liabilities 0.0 (12.5)
(Gain) loss on investments, net (31.6) 6.4
Deferred income taxes 130.1 (63.2)
Gain on remeasurement of previously held interest upon business combinations (Note 7) (85.1) 0.0
Loss on impairment (Note 6) 163.6 47.1
Other (1.3) (4.1)
Changes in operating assets and liabilities:    
Accounts and other receivables, net (148.0) (55.4)
Inventories (49.7) 39.7
Accounts payable and accrued liabilities (156.2) 226.4
Income taxes 97.7 (199.4)
Prepaid expenses and other current assets (2.0) (17.5)
Intellectual property agreement accrual (50.0) (61.7)
Other (27.1) (31.8)
Net cash provided by operating activities 1,266.0 1,144.3
Cash flows from investing activities    
Capital expenditures (195.4) (162.8)
Investments in unconsolidated affiliates (13.7) (49.8)
Purchases of held-to-maturity investments (Note 5) (39.1) (43.2)
Proceeds from held-to-maturity investments (Note 5) 39.2 54.2
Purchases of available-for-sale investments (Note 5) (1,855.5) (2,265.2)
Proceeds from available-for-sale investments (Note 5) 1,624.4 2,109.4
Payment for working capital adjustment for sale of product group (Note 4) 0.0 (36.3)
Business combinations, net of cash (Note 7) (33.7) 0.0
Payment for acquisition options (4.0) (19.6)
Issuances of notes receivable (55.2) (93.4)
Other (9.4) (7.9)
Net cash used in investing activities (542.4) (514.6)
Cash flows from financing activities    
Purchases of treasury stock (714.0) (852.8)
Purchase of remaining noncontrolling interest in subsidiary (Note 6) 0.0 (233.7)
Proceeds from stock plans 159.2 141.8
Other 2.5 (0.7)
Net cash used in financing activities (552.3) (945.4)
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash 1.6 (48.3)
Net increase (decrease) in cash, cash equivalents, and restricted cash 172.9 (364.0)
Cash, cash equivalents, and restricted cash at beginning of period 2,939.5 3,058.8
Cash, cash equivalents, and restricted cash at end of period (Note 2) $ 3,112.4 $ 2,694.8